Westfield Capital Management CO LP Vaxcyte, Inc. Transaction History
Westfield Capital Management CO LP
- $21.6 Billion
- Q4 2024
A detailed history of Westfield Capital Management CO LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 2,566,759 shares of PCVX stock, worth $205 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
2,566,759
Previous 1,739,874
47.53%
Holding current value
$205 Million
Previous $199 Million
5.78%
% of portfolio
0.97%
Previous 0.94%
Shares
6 transactions
Others Institutions Holding PCVX
# of Institutions
349Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$954 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$843 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$793 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$693 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$495 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.73B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...